K. Kelemen

Publications95
h-index14
Citations795
Highly Influential Citations19
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Knoll
  • 274 Publications, 5,561 Citations
  • H. Katus
  • 1,920 Publications, 67,093 Citations
  • A. Bauer
  • 75 Publications, 1,588 Citations
  • S. Nattel
  • 856 Publications, 53,332 Citations
  • Publications
  • Influence
Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.
  • 112
  • 5
Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.
AIMS Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and effective treatment of AF still remains an unmet medical need. AF is associated with atrial conduction disturbances… Expand
  • 125
  • 3
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.
AIMS Atrial fibrillation (AF) is linked to cardiomyocyte apoptosis, leading to atrial remodelling and reduction in electrical conduction velocity. We hypothesized that genetic suppression of an… Expand
  • 66
  • 3
  • PDF
Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator
AbstractArrhythmia induction during implantation of cardioverter defibrillators (ICD) is a standard procedure. However, controversy exists regarding the need for routine arrhythmia induction before… Expand
  • 11
  • 2
Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.
The catechin EGCG is the main flavonoid compound of green tea and has received enormous pharmacological attention because of its putative beneficial health effects. This study investigated for the… Expand
  • 32
  • 1
Ventricular tachycardia from the healed myocardial infarction scar: validation of an animal model and utility of gene therapy.
Life-threatening ventricular arrhythmias generally occur in the setting of structural heart disease. Current clinical options for patients at risk for these rhythm disturbances are limited. We… Expand
  • 25
  • 1
Tridimensional activation patterns of acquired torsade-de-pointes-tachycardias in dogs with chronic AV-block
Abstract.Background:Dogs with chronic AV block exposed to type-III antiarrhythmic agents develop polymorphic ventricular tachycardias (PVT). Controversy exists regarding PVT mechanism and underlying… Expand
  • 24
  • 1
Biological Heart Rate Reduction Through Genetic Suppression of Gαs Protein in the Sinoatrial Node
Background Elevated heart rate represents an independent risk factor for cardiovascular outcome in patients with heart disease. In the sinoatrial node, rate increase is mediated by β1 adrenoceptor… Expand
  • 16
  • 1
  • PDF
Physiological and pharmacological analysis of transmembrane action potentials of human atrial fibers.
Transmembrane action potentials (APs) of electrically paced right-atrial tissue obtained from 38 patients of corrective open-heart surgery were analyzed. Two types of APs could be found. The APs of… Expand
  • 9
  • 1
Young Investigator Awards Session
  • 2
  • 1